Renaissance Technologies’s Dogwood Therapeutics DWTX Stock Holding History

Renaissance Technologies’s Portfolio DWTX Stock Details DWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-660	Closed	-$2.8K	–	3977
2024 Q3	$2.8K	Buy	+660	New	+$3.42K	﹤0.01%	3482
2024 Q1	–	Sell	-8,268	Closed	-$119K	–	4152
2023 Q4	$119K	Buy	8,268 +7,708	+1,376%	+$130K	﹤0.01%	3260
2023 Q3	$13K	Sell	560 -1,296	-70%	-$45.1K	﹤0.01%	3570
2023 Q2	$64K	Sell	1,856 -80	-4%	-$2.28K	﹤0.01%	3569
2023 Q1	$18K	Sell	1,936 -7,480	-79%	-$59.5K	﹤0.01%	3841
2022 Q4	$56K	Buy	9,416 +2,352	+33%	+$17.7K	﹤0.01%	3779
2022 Q3	$67K	Buy	+7,064	New	+$995K	﹤0.01%	3694

Other funds holding DWTX

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

BPI

BFC Planning, Inc. Cedar Rapids, Iowa $2.46B AUM 38.2% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies's DWTX Position: Q4 2024 in Review

Renaissance Technologies sold out of Dogwood Therapeutics (DWTX) in Q4 2024, closing a stake of 660 shares — an estimated $2.8K sold.

Renaissance Technologies first reported a position in DWTX in Q3 2022 and held it in 7 quarters. The position peaked at $119K in Q4 2023. 11 funds tracked by Wall St. Rank hold DWTX as of Q4 2024.

Renaissance Technologies reported no remaining Dogwood Therapeutics position as of Q4 2024 after selling out during the quarter.
Renaissance Technologies sold 660 Dogwood Therapeutics shares in Q4 2024, an estimated $2.8K.
Renaissance Technologies first reported a position in Dogwood Therapeutics in Q3 2022 and held it in 7 quarters.
Renaissance Technologies's Dogwood Therapeutics position peaked at $119K in Q4 2023.
11 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q4 2024.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.